The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease.
$3M grant awarded to examine Ozempic effect on Crohn's disease
The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease.